N83.339 Acquired atrophy of ovary and fallopian tube, unspecified side

Name of the Condition

• Acquired atrophy of ovary and fallopian tube, unspecified side

Summary

Acquired atrophy of the ovary and fallopian tube, unspecified side, refers to the progressive reduction in size and function of these reproductive structures due to non-congenital factors, without specifying the affected side. This condition may result from hormonal changes, reduced blood supply, or other acquired influences, leading to diminished tissue volume and potential functional impairment.

Causes

Acquired atrophy typically arises from factors such as hormonal imbalances (e.g., menopause), reduced ovarian or tubal blood flow, chronic inflammation, or prolonged disuse. Conditions like ischemia, autoimmune processes, or prolonged estrogen deficiency can contribute to tissue degeneration over time.

Risk Factors

• Advanced age (e.g., postmenopausal status)
• Chronic hormonal imbalances
• History of pelvic inflammatory disease
• Previous surgeries affecting ovarian or tubal blood supply
• Autoimmune disorders

Symptoms

• Irregular or absent menstrual cycles
• Vaginal dryness or atrophy
• Pelvic discomfort or pressure
• Reduced fertility or infertility
• Changes in sexual function

Diagnosis

Pelvic examination to assess tissue consistency and size. Imaging studies (e.g., ultrasound, MRI) to evaluate structural changes. Hormonal testing to identify deficiencies or imbalances. In some cases, biopsy may be performed to rule out other conditions.

Treatment Options

Treatment focuses on addressing underlying causes and managing symptoms. Hormone replacement therapy may be used to alleviate symptoms of estrogen deficiency. Pain management strategies can help with pelvic discomfort. Fertility preservation options may be considered if reproductive function is a concern. Regular monitoring is recommended to assess tissue changes over time.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of atrophy. Early intervention may help slow progression, but some functional impairment may be irreversible. Follow-up care typically includes regular pelvic examinations and imaging to monitor tissue changes. Hormonal or symptomatic management may be ongoing, with adjustments based on clinical response.

Complications

Potential complications include persistent infertility, chronic pelvic pain, or increased risk of osteoporosis due to prolonged estrogen deficiency. In rare cases, atrophy may be associated with an increased risk of certain gynecological conditions, though this is not universally observed.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including balanced nutrition and regular exercise, may support overall reproductive health. Avoiding smoking and excessive alcohol use can help preserve tissue function. Managing chronic conditions like diabetes or autoimmune disorders may reduce risk. Regular gynecological check-ups can aid in early detection and intervention.

When to Seek Professional Help

Seek medical attention if experiencing persistent pelvic pain, significant changes in menstrual patterns, or unexplained infertility. Sudden or severe symptoms, such as acute pelvic discomfort or abnormal bleeding, warrant prompt evaluation to rule out other conditions.

Tips for Medical Coders

When coding N83.339, ensure documentation specifies "unspecified side" to align with the code's designation. Verify that the atrophy is acquired (non-congenital) and affects both ovary and fallopian tube. Confirm no laterality is documented, as the code is for unspecified side. Review clinical notes for details on etiology, symptoms, or associated conditions to support accurate coding.